Social Psychology May Help With Physician Error Disclosure

This article originally appeared here.
Share this content:
Social Psychology May Help With Physician Error Disclosure
Social Psychology May Help With Physician Error Disclosure

TUESDAY, May 30, 2017 (HealthDay News) -- Lessons from social psychology can be used to improve behavioral changes in terms of error disclosure, according to research published online May 18 in Medical Education.

Jason Han, from the Perelman School of Medicine in Philadelphia, and colleagues address the social psychology principles that may influence physician behavior in terms of error disclosure. They reviewed recent administrative measures designed to encourage error disclosure, noting that deliberate practice, together with lessons from social psychology, can promote productive behavioral changes.

The authors identified two main cognitive biases that may hinder disclosure of errors: fundamental attribution error and forecasting error. Strategies are available to overcome these maladaptive cognitive patterns. Interactions with standardized patients can help to simulate hospital encounters and teach behavioral considerations. Virtual reality is an immersive, realistic, and scalable technology that can be used to supplement traditional curricula. In addition, establishing a professional standard of competence is highlighted, potentially by including difficult patient encounters (e.g., error disclosure) into medical licensing examinations, which evaluate clinical skills.

"Existing curricula that cover physician error disclosure may benefit from reviewing the social psychology literature," the authors write. "These lessons, incorporated into standardized patient programs and emerging technological platforms, may improve training and evaluative methods for all medical trainees."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »